Extended Safety, Immunogenicity and Efficacy of a Blood-Stage Malaria Vaccine in Malian Children: 24-Month Follow-Up of a Randomized, Double-Blinded Phase 2 Trial

• Matthew B. Laurens,

  Affiliation Malaria Group, Howard Hughes Medical Institute/Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, United States of America

  ⨯
• Mahamadou A. Thera,

  Affiliation Malaria Research and Training Center, University of Science, Techniques and Technology, Bamako, Mali

  ⨯
• Drissa Coulibaly,

  Affiliation Malaria Research and Training Center, University of Science, Techniques and Technology, Bamako, Mali

  ⨯
• Amed Ouattara,

  Affiliations Malaria Group, Howard Hughes Medical Institute/Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, United States of America, Malaria Research and Training Center, University of Science, Techniques and Technology, Bamako, Mali

  ⨯
• Abdoulaye K. Kone,

  Affiliation Malaria Research and Training Center, University of Science, Techniques and Technology, Bamako, Mali

  ⨯
• Ando B. Guindo,

  Affiliation Malaria Research and Training Center, University of Science, Techniques and Technology, Bamako, Mali

  ⨯
• Karim Traore,

  Affiliation Malaria Research and Training Center, University of Science, Techniques and Technology, Bamako, Mali

  ⨯
• Idrissa Traore,

  Affiliation Malaria Research and Training Center, University of Science, Techniques and Technology, Bamako, Mali

  ⨯
• Bourema Kouriba,

  Affiliation Malaria Research and Training Center, University of Science, Techniques and Technology, Bamako, Mali

  ⨯
• Dapa A. Diallo,

  Affiliation Malaria Research and Training Center, University of Science, Techniques and Technology, Bamako, Mali

  ⨯
• Issa Diarra,

  Affiliation Malaria Research and Training Center, University of Science, Techniques and Technology, Bamako, Mali

  ⨯
• Modibo Daou,

  Affiliation Malaria Research and Training Center, University of Science, Techniques and Technology, Bamako, Mali

  ⨯
• Amagana Dolo,

  Affiliation Malaria Research and Training Center, University of Science, Techniques and Technology, Bamako, Mali

  ⨯
• Youssouf Tolo,

  Affiliation Malaria Research and Training Center, University of Science, Techniques and Technology, Bamako, Mali

  ⨯
• Mahamadou S. Sissoko,

  Affiliation Malaria Research and Training Center, University of Science, Techniques and Technology, Bamako, Mali

  ⨯
• Amadou Niangaly,

  Affiliation Malaria Research and Training Center, University of Science, Techniques and Technology, Bamako, Mali

  ⨯
• Mady Sissoko,

  Affiliation Malaria Research and Training Center, University of Science, Techniques and Technology, Bamako, Mali

  ⨯
• Shannon Takala-Harrison,

  Affiliation Malaria Group, Howard Hughes Medical Institute/Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, United States of America

  ⨯
• Kirsten E. Lyke,

  Affiliation Malaria Group, Howard Hughes Medical Institute/Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, United States of America

  ⨯
• Yukun Wu,

  Affiliation Malaria Group, Howard Hughes Medical Institute/Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, United States of America

  ⨯
• William C. Blackwelder,

  Affiliation Malaria Group, Howard Hughes Medical Institute/Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, United States of America

  ⨯
• Olivier Godeaux,

  Affiliation GlaxoSmithKline Vaccines, Rixensart, Belgium

  ⨯
• Johan Vekemans,

  Affiliation GlaxoSmithKline Vaccines, Rixensart, Belgium

  ⨯
• Marie-Claude Dubois,

  Affiliation GlaxoSmithKline Vaccines, Rixensart, Belgium

  ⨯
• W. Ripley Ballou,

  Affiliation GlaxoSmithKline Vaccines, Rixensart, Belgium

  ⨯
• Joe Cohen,

  Affiliation GlaxoSmithKline Vaccines, Rixensart, Belgium

  ⨯
• Tina Dube,

  Affiliation EMMES Corporation, Rockville, Maryland, United States of America

  ⨯
• Lorraine Soisson,

  Affiliation Malaria Vaccine Development Program, U.S. Agency for International Development, Washington, DC, United States of America

  ⨯
• Carter L. Diggs,

  Affiliation Malaria Vaccine Development Program, U.S. Agency for International Development, Washington, DC, United States of America

  ⨯
• Brent House,

  Affiliation U.S. Military Malaria Vaccine Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America

  ⨯
• Jason W. Bennett,

  Affiliation U.S. Military Malaria Vaccine Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America

  ⨯
• David E. Lanar,

  Affiliation U.S. Military Malaria Vaccine Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America

  ⨯
• Sheetij Dutta,

  Affiliation U.S. Military Malaria Vaccine Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America

  ⨯
• D. Gray Heppner,

  Affiliation U.S. Military Malaria Vaccine Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America

  ⨯
• Christopher V. Plowe ,

  * E-mail: cplowe@medicine.umaryland.edu

  Affiliation Malaria Group, Howard Hughes Medical Institute/Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, United States of America

  ⨯
•  [ ... ],
• Ogobara K. Doumbo

  Affiliation Malaria Research and Training Center, University of Science, Techniques and Technology, Bamako, Mali

  ⨯
• [ view all ]
• [ view less ]